TrialAdvances in therapy2016

nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma: Canadian Subgroup Analysis of the Phase 3 MPACT Trial.

Mustapha Tehfe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.